The UH Cancer Center’s Hawaiʻi Tumor Registry releases updated cancer statistics in “Hawaiʻi Cancer at a Glance, 2012-2016”

June 8, 2020

Hawaiʻi Cancer at a Glance, 2012-2016

The University of Hawaiʻi Cancer Center’s Hawaiʻi Tumor Registry released updated cancer statistics in a publication, “Hawaiʻi Cancer at a Glance, 2012-2016.” The publication’s contents include data on cancer incidence and mortality in the state of Hawaiʻi.

Hawaiʻi is a diverse state in its geography, as well as in its demographics. In addition to having no ethnic majority, it has the highest proportion of individuals of mixed-race ethnicity in the U.S., with two of every ten residents describing themselves as more than one race. “Hawaiʻi Cancer at a Glance, 2012-2016,” acknowledges this diversity, and examines variation in cancer incidence and mortality by county and across various racial and ethnic groups. “Disparities in cancer risk and outcomes across racial and ethnic groups may reflect genetic variation as well as differences in diet, tobacco and alcohol use, obesity, and other lifestyle exposures,” Hawaiʻi Tumor Registry Principal Investigator, Brenda Hernandez, PhD, MPH, said.

Annually, an average of 7,010 Hawaiʻi residents are newly diagnosed with invasive cancer and 2,347 individuals die of cancer. There are over 62,000 cancer survivors in the state. The reports show that breast cancer remains the most frequently diagnosed cancer among women, while prostate cancer is the most common cancer among men. Hawaiʻi’s liver and stomach cancer incidence and mortality rates are significantly higher than the U.S., and lung cancer continues to be the leading cause of cancer death in the state. Key ethnic differences were also observed. Lung cancer incidence is highest in Filipino and Native Hawaiian men, and in Native Hawaiian women. Thyroid cancer incidence is highest in Filipino women. Liver cancer incidence and mortality are highest in Native Hawaiian men, and whites (both men and women) have the highest rates of melanoma.

The Hawaiʻi Tumor Registry is responsible for cancer surveillance in the state of Hawaiʻi. It is a funded registry of the National Cancer Institute (NCI) Surveillance Epidemiology and End Results (SEER) Program . The Hawaiʻi Tumor Registry collects confidential data on cancer diagnosis, treatment, and outcomes. These data are used to track cancer trends in the state and nation. “Tracking the rate of new cancer cases and deaths is critically important for the UH Cancer Center’s research on cancer prevention, early detection, treatment, and survivorship,” Hernandez said. Publications from NCI SEER registries, such as “Hawaiʻi Cancer at a Glance, 2012-2016,” serve as an important resource for cancer research and public health activities throughout the nation.

This project has been funded in whole or in part with Federal funds from the National Cancer Institute, National Institutes of Health, Department of Health and Human Services, under Contract No. HHSN261201800011I.